chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt had received Pfizer booster around 12/1/2021.  Developed chest pain associated with syncope and was hospitalized on 12/19/2021 with a DVT in the right leg.   No previous history of clots and no family history of clots. PCM does suspect his clot is related to having gotten the Pfizer booster 3 weeks ago.  DOAC was started on pt for DVT treatment.
Febrile illness an robust local reaction within 3 days of vaccination; Pleuritic pain 7 days s/p vaccine; Hospitalized with ácardiac enzymes, abnormal ECG and ECHO 10 days s/p vaccination
Pain down her left arm; Red and itchy down her arm; Red and itchy down her arm; Low grade fever of 101 or less; Pain all over her body; Soreness around injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain down her left arm), ERYTHEMA (Red and itchy down her arm), PRURITUS (Red and itchy down her arm), VACCINATION SITE PAIN (Soreness around injection site) and PYREXIA (Low grade fever of 101 or less) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness around injection site) and MYALGIA (Pain all over her body). On 18-Mar-2021, the patient experienced PYREXIA (Low grade fever of 101 or less). On 23-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain down her left arm), ERYTHEMA (Red and itchy down her arm) and PRURITUS (Red and itchy down her arm). The patient was treated with PARACETAMOL (TYLENOL) (oral) for Pain, at an unspecified dose and frequency. On 18-Mar-2021, PYREXIA (Low grade fever of 101 or less) and MYALGIA (Pain all over her body) had resolved. At the time of the report, PAIN IN EXTREMITY (Pain down her left arm), ERYTHEMA (Red and itchy down her arm), PRURITUS (Red and itchy down her arm) and VACCINATION SITE PAIN (Soreness around injection site) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 101 (High) Body temperature was 101 degree Fahrenheit or less.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided.
- Red, bumpy rash at site of immunizations on L thigh. Localized to area around inj. site X 5 days. - Dx probable varicella, - Plan-watch for spread or signs of infection.
Hospitalized 11/20/2021; COVID-19 positive 11/13/2021; fully vaccinated  BRIEF OVERVIEW:  Admission Date: 11/20/2021 Discharge Date: Nov 24, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID [U07.1] COVID-19 [U07.1] Generalized weakness [R53.1] HOSPITAL COURSE: Patient is a 97-year-old male with a past medical history of hypertension, CVA on Eliquis, CKD stage 3, diabetes mellitus type 2, dyslipidemia BPH who presented from his independent living facility with generalized weakness.  He had 6 days of progressive weakness prior to admission.  This included an assisted fall to the ground by family.  He did not hit his head or lose consciousness.  He also complained of shortness of breath and ?brain fog ?.  He tested positive for COVID-19 on November 13, 2021. He was fully vaccinated with Moderna vaccine.  He was febrile in the emergency department at 38.3.  Otherwise his vital signs were unremarkable.  Chest x-ray showed bilateral patchy opacities consistent with COVID-19 pneumonia.  He was not hypoxic.  He was placed in observation status initially.  He did qualify for monoclonal antibodies.  He received this and tolerated it well.  He did not qualify for Decadron or remdesivir as he was not hypoxic.  The patient's weakness persisted.  PT/OT recommended acute rehab.  He was discharged to acute rehab on 11/24/2021.  Rehab admission note 11/24/2021: HISTORY OF PRESENT ILLNESS: History was obtained from the patient as well as extensive chart review which is highlighted and summarized below   97 y.o. male with pmh of Carotid artery disease, CKD 3, GERD, HTN, HLD, peripheral neuropathy, hx of CVA, aortic arch thrombus who was admitted with progressive weakness, sob and brain fog found to be secondary to covid pneumonia. Patient tested positive on 11/15, patient is fully vaccinated. He was febrile on admission.  Patient had XR that showed patchy opacities in bilateral bases and left mid lung consistent with covid pneumonia. He was not a candidate for decadron, or remdesivir as he was no hypoxic. He did get monoclonal antibody therapy and tolerated it well. His hospital stay was otherwise uncomplicated though he is quite debilitated and deconditioned.   Prior to  hospitalization the patient was functionally independent with mobility and ADLs. Since his hospitalization he has had a functional decline to where he is now requiring mion assist bathing, transfers and ambulation. Due to his functional decline he will be admitted to inpatient rehab.
6 hours after injectionSwelling of left tonsil followed by right tonsil . Serious pain during swallowing and fever. All over body pain. Inability to sleep. Inability to speak. Inability to eat or drink for 2 weeks.
Patient had a CVA (stroke) to the R internal capsule and basal ganglia while therapeutic on warfarin. She has a history of Truncus Arteriosus s/p repair and has been anticoagulated for >10 years without issue. Stroke occurred 1 week after vaccine. She now has L sided motor deficits which are likely permanent. Left arm is flaccid. L leg with poor motor function.
extreme body aches; fatigue; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.A 44 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 26Feb2021 12:00 (Lot number: EN6201) at the age of 44 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hepatitis B" (unspecified if ongoing); "depression" (unspecified if ongoing); "insomnia" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number=EN6201, Administration time=12:00 PM, Administrator route=Intramuscular, Vaccine location=Left arm), administration date: 05Feb2021, when the patient was 44 years old, for COVID-19 immunisation. The following information was reported: PAIN (non-serious) with onset 27Feb2021 12:00, outcome "recovering", described as "extreme body aches"; FATIGUE (non-serious) with onset 27Feb2021 12:00, outcome "recovering", described as "fatigue". Therapeutic measures were not taken as a result of pain, fatigue.Additional information: The patient did not receive other vaccine product on the vaccination day. The facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed as COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. No follow-up attempts are needed. No further information is expected.
Tingling, numbness, and generalized weakness on left extremities (arm, hand, leg, foot).
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (sore arm) and arthralgia (sore shoulder) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 024M20A) for COVID-19 immunization. No medical history reported. On Apr 12, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Apr 12, 2021, patient experienced  pain in extremity (sore arm) and arthralgia (sore shoulder). The patient treated with Tylenol (paracetamol) for pain in arm and shoulder pain, at an unspecified dose and frequency. At the time of the report, pain in extremity (sore arm) and arthralgia (sore shoulder) outcome: unknown. Concomitant medications not provided.
COVID-19 Treatment; COVID-19 Treatment; This is a spontaneous report received from a contactable reporter (consumer or other non HCP) from product quality group. The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 04Apr2022 as dose number unknown, single (Lot number: FFJ9943) at the age of 67 years, in left arm for COVID-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of COVID-19.
Nausea, vomiting, fever, chills, shaking, body aches, migraine
Fever; Headache; Redness; Stiffness; Bruising; Neck pain; pain Swelling/Throbbing; pain Swelling; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER; Solution for injection; Lot number: EL3302, COVID 19) administered in left arm via an unspecified route of administration on 25Feb2021 at 11:30 AM at single dose for COVID-19 immunization. Medical history included Sarcoma cancer (amputated hand), heart failure, patient was allergic to Morphine, nitroglycerin, pertussis, walnuts, corn and bees. Concomitant medications were not reported. On 04Feb2021 at 12:30 PM, patient received first dose of BNT162B2 (PFIZER; Solution for injection; Lot number: EL0142) administered in left arm for covid-19 immunization. No other vaccine was given in four weeks. It was reported that patient was given other medications in two weeks: 15 meds too many to list. On 25Feb2021 at 22:00, patient experienced fever, headache, redness, stiffness, bruising, neck pain, pain swelling and throbbing which resulted in doctor or other healthcare professional office/clinic visit, Disability or permanent damage. The patient received treatment with Meloxicam for 10 days for the events. The patient not had covid prior to vaccination. The patient not tested for covid post vaccination. The outcome of all events was reported as not recovered.
pt recv vax & exp tingling in lt arm & hand;the tingling progressed to rt side, chest & lt side of face;pt also exp gen achiness & non-well feeling;
mom called in & states child has lump on areas where DTAP & HIB were given;pt has been falling down quit a bit;mom instructed to take child to MD to have lump checked out;mom has been massaging the area;
no adverse event; the full dose was not administered to the patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age. Patient's medical history, concurrent conditions, concomitant medications and allergy history were not reported.  On 11-FEB-2022, the patient received the second in the series of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) (dose, route of administration, lot number, expiration date were not reported) for prophylaxis. The full dose was not administered to the patient (underdose). No adverse events were reported (no adverse event).
Patient described pain throughout her body and a "strange taste" in her throat. Immediately following the vaccine, patient stated she was unable to stand due to the pain and weakness. Patient sat for ~5 minutes in immunization room before stating the pain was subsiding and was able to stand and move to waiting area to continue monitoring.
I had low grade fever, fatigue, runny nose, loss of smell and taste, insomnia for one night. After a couple of weeks, I developed heart palpitations and I was extremely tired for a while. I got tested for COVID-19 on 09/13/2021 and it came back positive. They did not prescribe any medications, but I am still investigating my heart issues. They did a chest x-ray and EKG. The x-ray showed an inflammation in one of my lungs but according to my doctor is not too serious and the EKG was normal. I am scheduled for a heart ultrasound.
Pfizer COVID-19 given to this patient who is 11 years 11 months old. Patient will be 12 years of age on 8/27/21
Sore, red area 3-4" at injection site. Leg pain, both legs, worse knees to toes with tingling sensation - woke up during night 3-5 am - took TYLENOL, walked around - pain subsided 1-2 hrs. No pain in pm of 9/22/11.
loss of hearing in left ear; loss of sight in left eye; loss of left eye; demyelinating polyneuropathy; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.  On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, route of administration and anatomical location were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster).  On an unknown date, after receiving zoster vaccine live (ZOSTAVAX), patient suffered a demyelinating polyneuropathy, loss of hearing in left ear, loss of sight in left eye and ultimately the loss of left eye. As a result of these symptoms, patient was seen and treated by medical providers and was still under their care. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient's symptoms have resulted in physical limitations not present prior to using the vaccine. Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of zoster vaccine live (ZOSTAVAX), patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  All events were considered to be disabling by the reporter.  Upon internal review, demyelinating polyneuropathy, loss of hearing in left ear, loss of sight in left eye and ultimately the loss of left eye were considered to be medically significant.
The day following vaccination 8/4/21 at 9:40am patient became very tired, couldn't hold head up, pupil dilated, skin ashy and white, lips totally white, passed out. Parents called ambulance. O2 levels went down to 84%. Was transported to emergency room for evaluation. Received 02 and intravenous fluids. Did blood and urine test. By the time got to ER color had come back. Did EKG, observed all day. Released home to parents care.
It started with a cough that night went to work. The cough was consistent at work the coworkers asked me to call employee health. I was informed to get Covid test at 11:00 am when I got home took a nap. Upon waking had a fever, cough had gotten worse, exp breathing problems, abdominal pain, muscle ache and joint in knee/wrists swelling. I took Tylenol for fever went away and still feel exhausted. On this morning my fever was 99.7,still have cough, and trouble breathing after Nebulizer treatments. I have missed over 5 days of work.
Syncope.  Patient passed out 5 min after injection - has phobia of needles.  No Resp disestress VSS, A&Ox4.  Pt given juice and crackers.  Pt left w/ mother in stable condition under her own power.  Refused wheelchair.
Two days after the vaccine injection, patient started with couple hives on arms, legs and torso. Today it is all over arms, legs and torso. Patient states it is very itchy and painful. Patient has been taking Benadryl every day with a little comfort. Patient does not want to see MD due to cost. Patient states the vaccine probably triggered allergy reaction that she had years ago.
This spontaneous report was received from a healthcare worker via a company representative refer to unspecified number of patients (age, gender unknown). The healthcare worker reported that unspecified number of patients may have fainted after receiving a dose of GARDASIL (dates unspecified). This is one of several reports received from the same reporter (case# 1404USA010532 and 1404USA015348). Additional information has been requested.
I started getting symptoms of sore throat and ear issues. It felt like a bad cold or sinus infection. I took a PCR COVID-19 test that was positive. I was prescribed Paxlovid. My symptoms stayed at bay then within 4 days most symptoms were gone excepted stuffy ear and exhaustion.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Oct2022 at 15:30 as dose 5 (booster), single (Lot number: gh9693) at the age of 71 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: ATORVASTATIN, start date: 01Jan2020, stop date: 20Oct2022.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Oct2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with Paxlovid from 21Oct2022 to 25Oct2022.   Clinical Course: The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously received a COVID-19 Vaccine.
This spontaneous report as received from a 75 year old female patient with high blood pressure and with no drug reaction or allergies. The patient was vaccinated subcutaneously with a single dose of ZOSTAVAX on 06-NOV-2008 (Lot# and dose not reported). No other co-suspects were reported. Concomitant medications were reported as blood pressure pill, name unknown. On 06-JUL-2012 the patient experienced shingles. The shingles started on her right upper hip and had gone around her mid section and back. The patient had contacted her physician and had a diagnosed case of the shingles. She had been treated with valacyclovir hydrochloride 1mg. No lab diagnostics studies performed. At the time of this report the patient was recovering. Additional information has been requested.
On Sunday the 22nd I started having a scratchy throat. Monday I noticed that I had a low grade fever along with a head ache and my throat was hurting more than it had been. Tuesday I took a home test and that was positive for COVID-19. I then reached out to my PCP they met with me on that Thursday. My fever had gone up a little over the two days before that, and the cough was starting to cough up phlegm as well. When we met for my appointment I was doing better and I did not end up getting anything to treat my symptoms.
Information has been received from a licensed practical nurse concerning a 78 year old female who in June 2007, was vaccinated with a dose of ZOSTAVAX (Oka/Merck) (lot # 652936/0981F). In October 2007, the patient hand an outbreak of shingles. The physician believed that the patient did not have shingles but had a semi circular rash. Unspecified medical attention was sought. At the time of report the patient had not recovered. A product quality complaint was not involved. Additional information has been requested. The nurse is not interested inthe VZV by PCR analysis program. Follow-up information has been received from the L.P.N. who reiterated that the reported episode of shingles was not diagnosed as shingles whom evaluated by the physician on 16-Oct-2007. Follow-up information has been received from the L.P.N. who reiterated that the reported episode of shingles was not diagnosed when evaluated on 16-Oct-2007. Follow-up information has been received from the L.P.N. that stated the patient did not have shingles. No other information is available.
After 3 or 4 days, the injection site turned from pain to itch.  On the 9th day, rash developed and it has been like that for 3 days.
Hives at neck and right side of back accompanied by extreme itching/burning-36 hours after, increased zyrtec dosage; swollen face-16 hours after; metallic taste-onset was 4 hours from inject and persisted for 7 days; pimples/white heads on left arm-16 hours after injection and persisted through day 12; intermittent tremors/shaking hands-6 hours after injection and persisted through 48 hours; mental confusion/fog-4 hours after injection and persisted through 48 hours; left arm numbness from injection site to wrist-4 hours after injection, episodic persistence through day 4.
Headache, nausea, congestion, body aches,  soreness at injection site
Irritability followed by rapid heart beat that took place every 6 to 8 hours and lasted for about 2 hours each time. Next day redness at site of injection about 2.5 inches in diameter that welted up and was itchy. Injection site was also extremely warm to touch.  This all lasted for 8 days.  At present time injection site is still itchy. Took Benadryl to relieve symptoms.
Sharp back and stomach pain started 5/2/21. Went to ER 5/6/21. Ultrasound confirmed gall stones and severely inflamed gallbladder. Taken to immediate surgery for laparoscopic removal of gallbladder, 5/6/21, ~8-9pm. Discharged 5/8/21, ~2pm.